SCHEMBL19202634

SCHEMBL19202634

CCC(C)(C)c1ccc(F)c2ccoc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17772790 0.82 HTR2C (0.31)
SCHEMBL26014306 0.72 HTR2C (0.34)
SCHEMBL16381040 0.72 KCNA2 (0.34)
SCHEMBL19203370 0.69 MEN1 (0.35)
SCHEMBL17552739 0.69 RIPK1 (0.39)
SCHEMBL22023990 0.67 KCNA3 (0.37)
SCHEMBL26778135 0.66 HTR2C (0.34)
SCHEMBL22273250 0.66 RIPK1 (0.34)
SCHEMBL28171587 0.66 HTR2C (0.43)
SCHEMBL23363949 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884849-B2 Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-02-06 US disclosed
US-9770445-B2 Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-26 US disclosed
US-20170217938-A1 FLUORINATED BENZOFURANYL-PYRIMIDINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-03 US disclosed